Real-World Biologic Adherence, Persistence, and Monotherapy Comparisons in US Patients with Psoriasis: Results from IBM MarketScan® Databases
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Real-World Biologic Adherence, Persistence, and Monotherapy Comparisons in US Patients with Psoriasis: Results from IBM MarketScan® Databases ; volume:39 ; number:7 ; day:16 ; month:5 ; year:2022 ; pages:3214-3224 ; date:7.2022
Advances in therapy ; 39, Heft 7 (16.5.2022), 3214-3224, 7.2022
- Creator
-
Leonardi, Craig
Zhu, Baojin
Malatestinic, William N.
Eastman, William J.
Guo, Jiaying
Murage, Mwangi J.
Choong, Casey Kar-Chan
Burge, Russel
Blauvelt, Andrew
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-022-02155-9
- URN
-
urn:nbn:de:101:1-2022082009525729729779
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Leonardi, Craig
- Zhu, Baojin
- Malatestinic, William N.
- Eastman, William J.
- Guo, Jiaying
- Murage, Mwangi J.
- Choong, Casey Kar-Chan
- Burge, Russel
- Blauvelt, Andrew
- SpringerLink (Online service)
Other Objects (12)
Multiple treatment comparisons in epilepsy monotherapy trials
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Genomic and biologic comparisons of cyprinid herpesvirus 3 strains
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies
Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review
The Patient’s Guide to Psoriasis Treatment. Part 3: Biologic Injectables
Patients’ perspectives towards biologic dose reduction in psoriasis: a qualitative study
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
Dynamic QuantiFERON Response in Psoriasis Patients Taking Long-Term Biologic Therapy
Drug Persistence of Biologic Treatments in Psoriasis: A Swedish National Population Study
Increased radiographic progression of distal hand osteoarthritis occurring during biologic DMARD monotherapy for concomitant rheumatoid arthritis
Multiple treatment comparisons in epilepsy monotherapy trials
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Genomic and biologic comparisons of cyprinid herpesvirus 3 strains
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies
Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review
The Patient’s Guide to Psoriasis Treatment. Part 3: Biologic Injectables
Patients’ perspectives towards biologic dose reduction in psoriasis: a qualitative study
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
Dynamic QuantiFERON Response in Psoriasis Patients Taking Long-Term Biologic Therapy
Drug Persistence of Biologic Treatments in Psoriasis: A Swedish National Population Study
Increased radiographic progression of distal hand osteoarthritis occurring during biologic DMARD monotherapy for concomitant rheumatoid arthritis
Multiple treatment comparisons in epilepsy monotherapy trials
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Genomic and biologic comparisons of cyprinid herpesvirus 3 strains
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies
Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review
The Patient’s Guide to Psoriasis Treatment. Part 3: Biologic Injectables
Patients’ perspectives towards biologic dose reduction in psoriasis: a qualitative study
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
Dynamic QuantiFERON Response in Psoriasis Patients Taking Long-Term Biologic Therapy
Drug Persistence of Biologic Treatments in Psoriasis: A Swedish National Population Study